Originalartikel | erschienen - Druck | peer reviewed
Personalized cardiovascular medicine: concepts and methodological considerations.
Nature Reviews Cardiology
2013 ;
10(6):
308 - 316
Bibliometrische Indikatoren
Impact Factor = 10,154
DOI = 10.1038/nrcardio.2013.35
PubMed-ID = 23528962
Autoren
Völzke H*1, Schmidt C1, Baumeister S1, Ittermann T1, Fung G, Krafczyk-Korth J2,3, Hoffmann W3, Schwab M, Meyer zu Schwabedissen H4, Dörr M5, Felix S5, Lieb W1, Kroemer H4
Beteiligte Einrichtungen
1 - Institut für Community Medicine / Abt. SHIP KEF
2 - Institut für Hygiene und Umweltmedizin
3 - Institut für Community Medicine / Abt. Versorgungsepidemiologie und Community Health
4 - Institut für Pharmakologie / Abt. Allgemeine Pharmakologie
5 - Zentrum für Innere Medizin / Klinik für Innere Medizin B
Abstract
The primary goals of personalized medicine are to optimize diagnostic and treatment strategies by tailoring them to the specific characteristics of an individual patient. In this Review, we summarize basic concepts and methods of personalizing cardiovascular medicine. In-depth characterization of study participants and patients in general practice using standardized methods is a pivotal component of study design in personalized medicine. Standardization and quality assurance of clinical data are similarly important, but in daily practice imprecise definitions of clinical variables can reduce power and introduce bias, which limits the validity of the data obtained as well as their potential clinical applicability. Changes in statistical methods with personalized medicine include a shift from dichotomous outcomes towards continuously measured variables, predictive modelling, and individualized medical decisions, subgroup analyses, and data-mining strategies. A variety of approaches to personalized medicine exist in cardiovascular research and clinical practice that might have the potential to individualize diagnostic and therapeutic procedures. For some of the emerging methods, such as data mining, the most-efficient way to use these tools is not yet fully understood. In addition, the predictive models-although promising-are far from mature, and are likely to be greatly improved by using available large-scale data sets.
Veröffentlicht in
Nature Reviews Cardiology
| Jahr | 2013 |
| Impact Factor (2013) | 10,154 |
| Volume | 10 |
| Issue | 6 |
| Seiten | 308 - 316 |
| Open Access | nein |
| Peer reviewed | ja |
| Artikelart | Originalartikel |
| Artikelstatus | erschienen - Druck |
| DOI | 10.1038/nrcardio.2013.35 |
| PubMed-ID | 23528962 |
Allgemeine Daten zur Fachzeitschrift
Kurzbezeichnung: NAT REV CARDIOL
ISSN: 1759-5002
eISSN: 1759-5010
Land: ENGLAND
Sprache: English
Kategorie(n):
Impact Factor Entwicklung
ISSN: 1759-5002
eISSN: 1759-5010
Land: ENGLAND
Sprache: English
Kategorie(n):
- HEMATOLOGY
- PERIPHERAL VASCULAR DISEASE
Impact Factor Entwicklung
| Jahr | Impact Factor |
|---|---|
| 2010 | 7,467 |
| 2011 | 8,833 |
| 2012 | 10,4 |
| 2013 | 10,154 |
| 2014 | 9,183 |
| 2015 | 10,533 |
| 2016 | 14,299 |
| 2017 | 15,162 |
| 2018 | 17,42 |
| 2019 | 20,26 |
| 2020 | 32,43 |
| 2021 | 49,421 |
| 2022 | 49,6 |
| 2023 | 41,7 |
| 2024 | 44,2 |
Beteiligte Departments
Community Medicine
Projekte
GANI_MED Teilprojekt PB2 1: Kohorte 1 - Kardiovaskuläre Erkrankungen
GANI_MED Greifswald Approach to Individualized Medicine (Projektverbund)
GANI_MED Greifswald Approach to Individualized Medicine (Projektverbund)
Departments
Community Medicine
FAQs | Impressum | Datenschutz

